U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07463040) titled 'Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)' on Feb. 09.
Brief Summary: MAMS4CL comprises a clinical trial with three embedded sub-studies designed to comprehensively evaluate the administered treatments and assess the impact of CL treatment on patients and the healthcare system.
The multi-centre multi-arm multi-stage phase 3 clinical trial is designed to rigorously evaluate a total of 4 alternative treatment options for systemic CL against Sodium Stibugluconate (SSG) as the standard of care. The trial comprises two seamlessly linked stages. In stage 1, all four investigational arms ...